Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation.
Limited quarterly history available
Gross Margin needs at least three reported quarters before a meaningful chart is shown.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
N/A
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Avalyn Pharma Inc. Common Stock
Market Cap
$1.13B
Gross Margin
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
Gross Margin
73.28%
TTM Avg
75.19%
3Y Avg
72.82%
5Y Avg
72.76%
Market Cap
$1.14B
Gross Margin
88.05%
TTM Avg
93.34%
3Y Avg
92.32%
5Y Avg
92.94%
Market Cap
$1.14B
Gross Margin
47.68%
TTM Avg
50.27%
3Y Avg
51.23%
5Y Avg
48.58%
Market Cap
$1.11B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.15B
Gross Margin
99.36%
TTM Avg
84.41%
3Y Avg
76.16%
5Y Avg
77.91%
Market Cap
$1.11B
Gross Margin
56.01%
TTM Avg
52.19%
3Y Avg
51.27%
5Y Avg
51.81%
Market Cap
$1.10B
Gross Margin
76.23%
TTM Avg
76.19%
3Y Avg
76.96%
5Y Avg
77.39%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalyn Pharma Inc. Common Stock (AVLN) | $1.13B | 0.00% | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 73.28% | 75.19% | 72.82% | 72.76% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 88.05% | 93.34% | 92.32% | 92.94% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 47.68% | 50.27% | 51.23% | 48.58% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Nektar Therapeutics (NKTR)vs › | $1.15B | 99.36% | 84.41% | 76.16% | 77.91% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | 56.01% | 52.19% | 51.27% | 51.81% |
| STAAR Surgical Company (STAA)vs › | $1.10B | 76.23% | 76.19% | 76.96% | 77.39% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
